91 related articles for article (PubMed ID: 2865112)
1. Effect of uremia and anephric state on the pharmacokinetics of sulindac and its metabolites in rats. II. Differential effects on the biliary excretion.
Lin JH; Yeh KC; Duggan DE
Drug Metab Dispos; 1985; 13(5):608-13. PubMed ID: 2865112
[TBL] [Abstract][Full Text] [Related]
2. Effect of uremia and anephric state on the pharmacokinetics of sulindac and its metabolites in rats. I. An application of pharmacokinetic model for reversible metabolism.
Lin JH; Yeh KC; Duggan DE
Drug Metab Dispos; 1985; 13(5):602-7. PubMed ID: 2865111
[TBL] [Abstract][Full Text] [Related]
3. Biliary secretion of sulindac and metabolites in man.
Dobrinska MR; Furst DE; Spiegel T; Vincek WC; Tompkins R; Duggan DE; Davies RO; Paulus HE
Biopharm Drug Dispos; 1983; 4(4):347-58. PubMed ID: 6661513
[TBL] [Abstract][Full Text] [Related]
4. Renal metabolism of sulindac: functional implications.
Miller MJ; Bednar MM; McGiff JC
J Pharmacol Exp Ther; 1984 Nov; 231(2):449-56. PubMed ID: 6436473
[TBL] [Abstract][Full Text] [Related]
5. Effect of dimethyl sulfoxide on sulindac disposition in rats.
Swanson BN; Mojaverian P; Boppana VK; Dudash MR
Drug Metab Dispos; 1981; 9(6):499-502. PubMed ID: 6120805
[TBL] [Abstract][Full Text] [Related]
6. Inhibition of sulindac metabolism by dimethyl sulfoxide in the rat.
Swanson BN; Mojaverian P; Boppana VK
J Toxicol Environ Health; 1983; 12(2-3):213-22. PubMed ID: 6655731
[TBL] [Abstract][Full Text] [Related]
7. Enterohepatic circulation of sulindac and metabolites.
Dujovne CA; Pitterman A; Vincek WC; Dobrinska MR; Davies RO; Duggan DE
Clin Pharmacol Ther; 1983 Feb; 33(2):172-7. PubMed ID: 6822030
[TBL] [Abstract][Full Text] [Related]
8. In vitro metabolism of sulindac and sulindac sulfide: enzymatic formation of sulfoxide and sulfone.
Kitamura S; Tatsumi K
Jpn J Pharmacol; 1982 Oct; 32(5):833-8. PubMed ID: 7176218
[TBL] [Abstract][Full Text] [Related]
9. Kinetics of the tissue distributions of sulindac and metabolites. Relevance to sites and rates of bioactivation.
Duggan DE; Hooke KF; Hwang SS
Drug Metab Dispos; 1980; 8(4):241-6. PubMed ID: 6105058
[TBL] [Abstract][Full Text] [Related]
10. Comparison of the effects of sulindac with other cyclooxygenase inhibitors on prostaglandin excretion and renal function in normal and chronic bile duct-ligated dogs and swine.
Zambraski EJ; Chremos AN; Dunn MJ
J Pharmacol Exp Ther; 1984 Mar; 228(3):560-6. PubMed ID: 6423807
[TBL] [Abstract][Full Text] [Related]
11. Sulindac: therapeutic implications of the prodrug/pharmacophore equilibrium.
Duggan DE
Drug Metab Rev; 1981; 12(2):325-37. PubMed ID: 7040018
[TBL] [Abstract][Full Text] [Related]
12. Effects of age and disease on the pharmacokinetics and pharmacodynamics of sulindac.
Sitar DS; Owen JA; MacDougall B; Hunter T; Mitenko PA
Clin Pharmacol Ther; 1985 Aug; 38(2):228-34. PubMed ID: 4017423
[TBL] [Abstract][Full Text] [Related]
13. Biotransformation of sulindac in end-stage renal disease.
Gibson TP; Dobrinska MR; Lin JH; Entwistle LA; Davies RO
Clin Pharmacol Ther; 1987 Jul; 42(1):82-8. PubMed ID: 3595070
[TBL] [Abstract][Full Text] [Related]
14. Comparative disposition of sulindac and metabolites in five species.
Duggan DE; Hooke KF; Noll RM; Hucker HB; Van Arman CG
Biochem Pharmacol; 1978; 27(19):2311-20. PubMed ID: 103551
[No Abstract] [Full Text] [Related]
15. Pharmacokinetics of graded oral doses of sulindac in man.
Mattila J; Mäntylä R; Vuorela A; Lamminsivu U; Männistö P
Arzneimittelforschung; 1984; 34(2):226-9. PubMed ID: 6539116
[TBL] [Abstract][Full Text] [Related]
16. Thioredoxin-dependent sulfoxide reduction by rat renal cytosol.
Anders MW; Ratnayake JH; Hanna PE; Fuchs JA
Drug Metab Dispos; 1981; 9(4):307-10. PubMed ID: 6114827
[TBL] [Abstract][Full Text] [Related]
17. Exposure of rats to inhalational anesthetics alters the hepatobiliary clearance of cholephilic xenobiotics.
Watkins JB
J Pharmacol Exp Ther; 1989 Aug; 250(2):421-7. PubMed ID: 2760837
[TBL] [Abstract][Full Text] [Related]
18. Renal metabolism of sulindac, a novel nonsteroidal antiinflammatory agent.
Miller MJ; Bednar MM; McGiff JC
Adv Prostaglandin Thromboxane Leukot Res; 1983; 11():487-91. PubMed ID: 6221568
[No Abstract] [Full Text] [Related]
19. Analysis of sulindac and metabolites in plasma and urine by high-performance liquid chromatography.
Stubbs RJ; Ng LL; Entwistle LA; Bayne WF
J Chromatogr; 1987 Jan; 413():171-80. PubMed ID: 3558666
[TBL] [Abstract][Full Text] [Related]
20. Sulfoxide reduction. In vitro reduction of sulindac by rat hepatic cytosolic enzymes.
Ratnayake JH; Hanna PE; Anders MW; Duggan DE
Drug Metab Dispos; 1981; 9(2):85-7. PubMed ID: 6113122
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
